SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Omega Therapeutics, Inc. (OMGA) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+6211.4%).
- Analyst consensus target $9.00 (+6211.4% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 45/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — OMGA
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio2.49
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.80
Book Value / Share$0.00
Revenue / Share$0.06
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$9.00 (+6211.4%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.39 |
$0.00 |
$-18.53M |
- |
| 2020 |
$-0.63 |
$0.00 |
$-30.2M |
- |
| 2021 |
$-1.45 |
$144K |
$-69.16M |
-48029.2% |
| 2022 |
$-2.14 |
$2.07M |
$-102.64M |
-4951.1% |
| 2023 |
$-1.80 |
$3.09M |
$-97.43M |
-3148.9% |
